chr1-31424740-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_178865.5(SERINC2):c.259G>A(p.Asp87Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00507 in 1,610,488 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 28 hom., cov: 33)
Exomes 𝑓: 0.0043 ( 44 hom. )
Consequence
SERINC2
NM_178865.5 missense
NM_178865.5 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 4.55
Genes affected
SERINC2 (HGNC:23231): (serine incorporator 2) Predicted to be involved in several processes, including phosphatidylserine metabolic process; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; and positive regulation of serine C-palmitoyltransferase activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010059774).
BP6
Variant 1-31424740-G-A is Benign according to our data. Variant chr1-31424740-G-A is described in ClinVar as [Benign]. Clinvar id is 785935.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.012 (1824/152312) while in subpopulation AFR AF= 0.0327 (1361/41574). AF 95% confidence interval is 0.0313. There are 28 homozygotes in gnomad4. There are 906 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 28 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SERINC2 | NM_178865.5 | c.259G>A | p.Asp87Asn | missense_variant | 3/10 | ENST00000373709.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SERINC2 | ENST00000373709.8 | c.259G>A | p.Asp87Asn | missense_variant | 3/10 | 1 | NM_178865.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0120 AC: 1822AN: 152194Hom.: 28 Cov.: 33
GnomAD3 genomes
AF:
AC:
1822
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00548 AC: 1320AN: 240750Hom.: 12 AF XY: 0.00484 AC XY: 633AN XY: 130712
GnomAD3 exomes
AF:
AC:
1320
AN:
240750
Hom.:
AF XY:
AC XY:
633
AN XY:
130712
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00435 AC: 6343AN: 1458176Hom.: 44 Cov.: 33 AF XY: 0.00409 AC XY: 2964AN XY: 725118
GnomAD4 exome
AF:
AC:
6343
AN:
1458176
Hom.:
Cov.:
33
AF XY:
AC XY:
2964
AN XY:
725118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0120 AC: 1824AN: 152312Hom.: 28 Cov.: 33 AF XY: 0.0122 AC XY: 906AN XY: 74472
GnomAD4 genome
AF:
AC:
1824
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
906
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
16
ALSPAC
AF:
AC:
21
ESP6500AA
AF:
AC:
131
ESP6500EA
AF:
AC:
22
ExAC
AF:
AC:
686
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
0.0040
.;.;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at